Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Standard Biotools (LAB) Capital Expenditures (2016 - 2025)

Historic Capital Expenditures for Standard Biotools (LAB) over the last 16 years, with Q3 2025 value amounting to $886000.0.

  • Standard Biotools' Capital Expenditures fell 6070.95% to $886000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $11.2 million, marking a year-over-year increase of 12191.65%. This contributed to the annual value of $8.4 million for FY2024, which is 19512.54% up from last year.
  • As of Q3 2025, Standard Biotools' Capital Expenditures stood at $886000.0, which was down 6070.95% from $1.9 million recorded in Q2 2025.
  • In the past 5 years, Standard Biotools' Capital Expenditures ranged from a high of $6.9 million in Q1 2021 and a low of $78000.0 during Q4 2023
  • In the last 5 years, Standard Biotools' Capital Expenditures had a median value of $1.0 million in 2023 and averaged $1.9 million.
  • Per our database at Business Quant, Standard Biotools' Capital Expenditures plummeted by 9567.57% in 2021 and then soared by 423589.74% in 2024.
  • Quarter analysis of 5 years shows Standard Biotools' Capital Expenditures stood at $463000.0 in 2021, then soared by 63.07% to $755000.0 in 2022, then tumbled by 89.67% to $78000.0 in 2023, then surged by 4235.9% to $3.4 million in 2024, then tumbled by 73.8% to $886000.0 in 2025.
  • Its Capital Expenditures was $886000.0 in Q3 2025, compared to $1.9 million in Q2 2025 and $5.1 million in Q1 2025.